Skip to main content
Top
Published in: Virology Journal 1/2008

Open Access 01-12-2008 | Research

The YPLGVG sequence of the Nipah virus matrix protein is required for budding

Authors: Jared R Patch, Ziying Han, Sarah E McCarthy, Lianying Yan, Lin-Fa Wang, Ronald N Harty, Christopher C Broder

Published in: Virology Journal | Issue 1/2008

Login to get access

Abstract

Background

Nipah virus (NiV) is a recently emerged paramyxovirus capable of causing fatal disease in a broad range of mammalian hosts, including humans. Together with Hendra virus (HeV), they comprise the genus Henipavirus in the family Paramyxoviridae. Recombinant expression systems have played a crucial role in studying the cell biology of these Biosafety Level-4 restricted viruses. Henipavirus assembly and budding occurs at the plasma membrane, although the details of this process remain poorly understood. Multivesicular body (MVB) proteins have been found to play a role in the budding of several enveloped viruses, including some paramyxoviruses, and the recruitment of MVB proteins by viral proteins possessing late budding domains (L-domains) has become an important concept in the viral budding process. Previously we developed a system for producing NiV virus-like particles (VLPs) and demonstrated that the matrix (M) protein possessed an intrinsic budding ability and played a major role in assembly. Here, we have used this system to further explore the budding process by analyzing elements within the M protein that are critical for particle release.

Results

Using rationally targeted site-directed mutagenesis we show that a NiV M sequence YPLGVG is required for M budding and that mutation or deletion of the sequence abrogates budding ability. Replacement of the native and overlapping Ebola VP40 L-domains with the NiV sequence failed to rescue VP40 budding; however, it did induce the cellular morphology of extensive filamentous projection consistent with wild-type VP40-expressing cells. Cells expressing wild-type NiV M also displayed this morphology, which was dependent on the YPLGVG sequence, and deletion of the sequence also resulted in nuclear localization of M. Dominant-negative VPS4 proteins had no effect on NiV M budding, suggesting that unlike other viruses such as Ebola, NiV M accomplishes budding independent of MVB cellular proteins.

Conclusion

These data indicate that the YPLGVG motif within the NiV M protein plays an important role in M budding; however, involvement of any specific components of the cellular MVB sorting pathway in henipavirus budding remains to be demonstrated. Further investigation of henipavirus assembly and budding may yet reveal a novel mechanism(s) of viral assembly and release that could be applicable to other enveloped viruses or have therapeutic implications.
Appendix
Available only for authorised users
Literature
1.
go back to reference Eaton BT, Broder CC, Middleton D, Wang LF: Hendra and Nipah viruses: different and dangerous. Nat Rev Microbiol 2006, 4: 23-35. 10.1038/nrmicro1323CrossRefPubMed Eaton BT, Broder CC, Middleton D, Wang LF: Hendra and Nipah viruses: different and dangerous. Nat Rev Microbiol 2006, 4: 23-35. 10.1038/nrmicro1323CrossRefPubMed
2.
go back to reference Eaton BT, Mackenzie JS, Wang LF: Henipaviruses. In Fields Virology. 5th edition. Edited by: Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE. Philadelphia, PA: Lippincott Williams & Wilkins; 2007:1587-1600. Eaton BT, Mackenzie JS, Wang LF: Henipaviruses. In Fields Virology. 5th edition. Edited by: Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE. Philadelphia, PA: Lippincott Williams & Wilkins; 2007:1587-1600.
3.
go back to reference Field H, Young P, Yob JM, Mills J, Hall L, Mackenzie J: The natural history of Hendra and Nipah viruses. Microbes Infect 2001, 3: 307-314. 10.1016/S1286-4579(01)01384-3CrossRefPubMed Field H, Young P, Yob JM, Mills J, Hall L, Mackenzie J: The natural history of Hendra and Nipah viruses. Microbes Infect 2001, 3: 307-314. 10.1016/S1286-4579(01)01384-3CrossRefPubMed
4.
go back to reference Anonymous: Hendra Virus, Human, Equine – Australia (07): (Queensland). Pro-MED: International Society for Infectious Diseases 2008. Anonymous: Hendra Virus, Human, Equine – Australia (07): (Queensland). Pro-MED: International Society for Infectious Diseases 2008.
5.
go back to reference Bishop KA, Broder CC: Hendra and Nipah: Lethal Zoonotic Paramyxoviruses. In Emerging Infections. Edited by: Scheld WM, Hammer SM, Hughes JM. Washington, D.C.: American Society for Microbiology; 2008. Bishop KA, Broder CC: Hendra and Nipah: Lethal Zoonotic Paramyxoviruses. In Emerging Infections. Edited by: Scheld WM, Hammer SM, Hughes JM. Washington, D.C.: American Society for Microbiology; 2008.
6.
go back to reference Chua KB: Nipah virus outbreak in Malaysia. J Clin Virol 2003, 26: 265-275. 10.1016/S1386-6532(02)00268-8CrossRefPubMed Chua KB: Nipah virus outbreak in Malaysia. J Clin Virol 2003, 26: 265-275. 10.1016/S1386-6532(02)00268-8CrossRefPubMed
7.
go back to reference Chua KB, Bellini WJ, Rota PA, Harcourt BH, Tamin A, Lam SK, Ksiazek TG, Rollin PE, Zaki SR, Shieh W, et al.: Nipah virus: a recently emergent deadly paramyxovirus. Science 2000, 288: 1432-1435. 10.1126/science.288.5470.1432CrossRefPubMed Chua KB, Bellini WJ, Rota PA, Harcourt BH, Tamin A, Lam SK, Ksiazek TG, Rollin PE, Zaki SR, Shieh W, et al.: Nipah virus: a recently emergent deadly paramyxovirus. Science 2000, 288: 1432-1435. 10.1126/science.288.5470.1432CrossRefPubMed
8.
go back to reference Hsu VP, Hossain MJ, Parashar UD, Ali MM, Ksiazek TG, Kuzmin I, Niezgoda M, Rupprecht C, Bresee J, Breiman RF: Nipah virus encephalitis reemergence, Bangladesh. Emerg Infect Dis 2004, 10: 2082-2087.PubMedCentralCrossRefPubMed Hsu VP, Hossain MJ, Parashar UD, Ali MM, Ksiazek TG, Kuzmin I, Niezgoda M, Rupprecht C, Bresee J, Breiman RF: Nipah virus encephalitis reemergence, Bangladesh. Emerg Infect Dis 2004, 10: 2082-2087.PubMedCentralCrossRefPubMed
9.
go back to reference Harit AK, Ichhpujani RL, Gupta S, Gill KS, Lal S, Ganguly NK, Agarwal SP: Nipah/Hendra virus outbreak in Siliguri, West Bengal, India in 2001. Indian J Med Res 2006, 123: 553-560.PubMed Harit AK, Ichhpujani RL, Gupta S, Gill KS, Lal S, Ganguly NK, Agarwal SP: Nipah/Hendra virus outbreak in Siliguri, West Bengal, India in 2001. Indian J Med Res 2006, 123: 553-560.PubMed
10.
go back to reference Anonymous: Nipah virus, fatal – Bangladesh (03). Pro-med: International Society for Infectious Diseases 2008. Anonymous: Nipah virus, fatal – Bangladesh (03). Pro-med: International Society for Infectious Diseases 2008.
11.
go back to reference Anonymous: Nipah virus outbreak(s) in Bangladesh, January-April 2004. Wkly Epidemiol Rec 2004, 79: 168-171. Anonymous: Nipah virus outbreak(s) in Bangladesh, January-April 2004. Wkly Epidemiol Rec 2004, 79: 168-171.
12.
go back to reference Anonymous: Emerging Infections update: November 2004 to January 2005. Communicable Disease Report Weekly (CDR Weekly) 2005., 15: Anonymous: Emerging Infections update: November 2004 to January 2005. Communicable Disease Report Weekly (CDR Weekly) 2005., 15:
13.
go back to reference Anonymous: Nipah encephalitis outbreak over wide area of western Bangladesh, 2004. Health and Science Bulletin (ICDDR,B) 2004, 2: 7-11. Anonymous: Nipah encephalitis outbreak over wide area of western Bangladesh, 2004. Health and Science Bulletin (ICDDR,B) 2004, 2: 7-11.
14.
go back to reference Anonymous: Nipah virus, fatal – India (West Bengal) (02). Pro-med: International Society for Infectious Diseases 2007. Anonymous: Nipah virus, fatal – India (West Bengal) (02). Pro-med: International Society for Infectious Diseases 2007.
15.
go back to reference Harcourt BH, Lowe L, Tamin A, Liu X, Bankamp B, Bowden N, Rollin PE, Comer JA, Ksiazek TG, Hossain MJ, et al.: Genetic characterization of Nipah virus, Bangladesh, 2004. Emerg Infect Dis 2005, 11: 1594-1597.PubMedCentralCrossRefPubMed Harcourt BH, Lowe L, Tamin A, Liu X, Bankamp B, Bowden N, Rollin PE, Comer JA, Ksiazek TG, Hossain MJ, et al.: Genetic characterization of Nipah virus, Bangladesh, 2004. Emerg Infect Dis 2005, 11: 1594-1597.PubMedCentralCrossRefPubMed
16.
go back to reference Chadha MS, Comer JA, Lowe L, Rota PA, Rollin PE, Bellini WJ, Ksiazek TG, Mishra A: Nipah virus-associated encephalitis outbreak, Siliguri, India. Emerg Infect Dis 2006, 12: 235-240.PubMedCentralCrossRefPubMed Chadha MS, Comer JA, Lowe L, Rota PA, Rollin PE, Bellini WJ, Ksiazek TG, Mishra A: Nipah virus-associated encephalitis outbreak, Siliguri, India. Emerg Infect Dis 2006, 12: 235-240.PubMedCentralCrossRefPubMed
17.
go back to reference Gurley ES, Montgomery JM, Hossain MJ, Bell M, Azad AK, Islam MR, Molla MA, Carroll DS, Ksiazek TG, Rota PA, et al.: Person-to-person transmission of Nipah virus in a Bangladeshi community. Emerg Infect Dis 2007, 13: 1031-1037.PubMedCentralCrossRefPubMed Gurley ES, Montgomery JM, Hossain MJ, Bell M, Azad AK, Islam MR, Molla MA, Carroll DS, Ksiazek TG, Rota PA, et al.: Person-to-person transmission of Nipah virus in a Bangladeshi community. Emerg Infect Dis 2007, 13: 1031-1037.PubMedCentralCrossRefPubMed
18.
go back to reference Chua KB, Lek Koh C, Hooi PS, Wee KF, Khong JH, Chua BH, Chan YP, Lim ME, Lam SK: Isolation of Nipah virus from Malaysian Island flying-foxes. Microbes Infect 2002, 4: 145-151. 10.1016/S1286-4579(01)01522-2CrossRefPubMed Chua KB, Lek Koh C, Hooi PS, Wee KF, Khong JH, Chua BH, Chan YP, Lim ME, Lam SK: Isolation of Nipah virus from Malaysian Island flying-foxes. Microbes Infect 2002, 4: 145-151. 10.1016/S1286-4579(01)01522-2CrossRefPubMed
19.
go back to reference Reynes JM, Counor D, Ong S, Faure C, Seng V, Molia S, Walston J, Georges-Courbot MC, Deubel V, Sarthou JL: Nipah virus in Lyle's flying foxes, Cambodia. Emerg Infect Dis 2005, 11: 1042-1047.PubMedCentralCrossRefPubMed Reynes JM, Counor D, Ong S, Faure C, Seng V, Molia S, Walston J, Georges-Courbot MC, Deubel V, Sarthou JL: Nipah virus in Lyle's flying foxes, Cambodia. Emerg Infect Dis 2005, 11: 1042-1047.PubMedCentralCrossRefPubMed
20.
go back to reference Luby SP, Rahman M, Hossain MJ, Blum LS, Husain MM, Gurley E, Khan R, Ahmed BN, Rahman S, Nahar N, et al.: Foodborne transmission of Nipah virus, Bangladesh. Emerg Infect Dis 2006, 12: 1888-1894.PubMedCentralCrossRefPubMed Luby SP, Rahman M, Hossain MJ, Blum LS, Husain MM, Gurley E, Khan R, Ahmed BN, Rahman S, Nahar N, et al.: Foodborne transmission of Nipah virus, Bangladesh. Emerg Infect Dis 2006, 12: 1888-1894.PubMedCentralCrossRefPubMed
21.
go back to reference Lamb RA, Kolakofsky D: Paramyxoviridae : The viruses and their replication. In Fields Virology. 4th edition. Edited by: Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE. Philadelphia, PA: Lippincott Williams & Wilkins; 2001:1305-1340. Lamb RA, Kolakofsky D: Paramyxoviridae : The viruses and their replication. In Fields Virology. 4th edition. Edited by: Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE. Philadelphia, PA: Lippincott Williams & Wilkins; 2001:1305-1340.
22.
go back to reference Patch JR, Crameri G, Wang LF, Eaton BT, Broder CC: Quantitative analysis of Nipah virus proteins released as virus-like particles reveals central role for the matrix protein. Virol J 2007, 4: 1. 10.1186/1743-422X-4-1PubMedCentralCrossRefPubMed Patch JR, Crameri G, Wang LF, Eaton BT, Broder CC: Quantitative analysis of Nipah virus proteins released as virus-like particles reveals central role for the matrix protein. Virol J 2007, 4: 1. 10.1186/1743-422X-4-1PubMedCentralCrossRefPubMed
23.
go back to reference Ciancanelli MJ, Basler CF: Mutation of YMYL in the Nipah virus matrix protein abrogates budding and alters subcellular localization. J Virol 2006, 80: 12070-12078. 10.1128/JVI.01743-06PubMedCentralCrossRefPubMed Ciancanelli MJ, Basler CF: Mutation of YMYL in the Nipah virus matrix protein abrogates budding and alters subcellular localization. J Virol 2006, 80: 12070-12078. 10.1128/JVI.01743-06PubMedCentralCrossRefPubMed
24.
go back to reference Sugahara F, Uchiyama T, Watanabe H, Shimazu Y, Kuwayama M, Fujii Y, Kiyotani K, Adachi A, Kohno N, Yoshida T, Sakaguchi T: Paramyxovirus Sendai virus-like particle formation by expression of multiple viral proteins and acceleration of its release by C protein. Virology 2004, 325: 1-10. 10.1016/j.virol.2004.04.019CrossRefPubMed Sugahara F, Uchiyama T, Watanabe H, Shimazu Y, Kuwayama M, Fujii Y, Kiyotani K, Adachi A, Kohno N, Yoshida T, Sakaguchi T: Paramyxovirus Sendai virus-like particle formation by expression of multiple viral proteins and acceleration of its release by C protein. Virology 2004, 325: 1-10. 10.1016/j.virol.2004.04.019CrossRefPubMed
25.
go back to reference Takimoto T, Murti KG, Bousse T, Scroggs RA, Portner A: Role of matrix and fusion proteins in budding of Sendai virus. J Virol 2001, 75: 11384-11391. 10.1128/JVI.75.23.11384-11391.2001PubMedCentralCrossRefPubMed Takimoto T, Murti KG, Bousse T, Scroggs RA, Portner A: Role of matrix and fusion proteins in budding of Sendai virus. J Virol 2001, 75: 11384-11391. 10.1128/JVI.75.23.11384-11391.2001PubMedCentralCrossRefPubMed
26.
go back to reference Coronel EC, Murti KG, Takimoto T, Portner A: Human parainfluenza virus type 1 matrix and nucleoprotein genes transiently expressed in mammalian cells induce the release of virus-like particles containing nucleocapsid-like structures. J Virol 1999, 73: 7035-7038.PubMedCentralPubMed Coronel EC, Murti KG, Takimoto T, Portner A: Human parainfluenza virus type 1 matrix and nucleoprotein genes transiently expressed in mammalian cells induce the release of virus-like particles containing nucleocapsid-like structures. J Virol 1999, 73: 7035-7038.PubMedCentralPubMed
27.
go back to reference Pantua HD, McGinnes LW, Peeples ME, Morrison TG: Requirements for the Assembly and Release of Newcastle Disease Virus-like particles. J Virol 2006, 80: 11062-11073. 10.1128/JVI.00726-06PubMedCentralCrossRefPubMed Pantua HD, McGinnes LW, Peeples ME, Morrison TG: Requirements for the Assembly and Release of Newcastle Disease Virus-like particles. J Virol 2006, 80: 11062-11073. 10.1128/JVI.00726-06PubMedCentralCrossRefPubMed
28.
go back to reference Chatziandreou N, Stock N, Young D, Andrejeva J, Hagmaier K, McGeoch DJ, Randall RE: Relationships and host range of human, canine, simian and porcine isolates of simian virus 5 (parainfluenza virus 5). J Gen Virol 2004, 85: 3007-3016. 10.1099/vir.0.80200-0CrossRefPubMed Chatziandreou N, Stock N, Young D, Andrejeva J, Hagmaier K, McGeoch DJ, Randall RE: Relationships and host range of human, canine, simian and porcine isolates of simian virus 5 (parainfluenza virus 5). J Gen Virol 2004, 85: 3007-3016. 10.1099/vir.0.80200-0CrossRefPubMed
29.
go back to reference Schmitt AP, Leser GP, Waning DL, Lamb RA: Requirements for budding of paramyxovirus simian virus 5 virus-like particles. J Virol 2002, 76: 3952-3964. 10.1128/JVI.76.8.3952-3964.2002PubMedCentralCrossRefPubMed Schmitt AP, Leser GP, Waning DL, Lamb RA: Requirements for budding of paramyxovirus simian virus 5 virus-like particles. J Virol 2002, 76: 3952-3964. 10.1128/JVI.76.8.3952-3964.2002PubMedCentralCrossRefPubMed
30.
go back to reference Bieniasz PD: Late budding domains and host proteins in enveloped virus release. Virology 2006, 344: 55-63. 10.1016/j.virol.2005.09.044CrossRefPubMed Bieniasz PD: Late budding domains and host proteins in enveloped virus release. Virology 2006, 344: 55-63. 10.1016/j.virol.2005.09.044CrossRefPubMed
31.
go back to reference Demirov DG, Freed EO: Retrovirus budding. Virus Res 2004, 106: 87-102. 10.1016/j.virusres.2004.08.007CrossRefPubMed Demirov DG, Freed EO: Retrovirus budding. Virus Res 2004, 106: 87-102. 10.1016/j.virusres.2004.08.007CrossRefPubMed
32.
go back to reference Morita E, Sundquist WI: Retrovirus budding. Annu Rev Cell Dev Biol 2004, 20: 395-425. 10.1146/annurev.cellbio.20.010403.102350CrossRefPubMed Morita E, Sundquist WI: Retrovirus budding. Annu Rev Cell Dev Biol 2004, 20: 395-425. 10.1146/annurev.cellbio.20.010403.102350CrossRefPubMed
33.
go back to reference Perez M, Craven RC, de la Torre JC: The small RING finger protein Z drives arenavirus budding: implications for antiviral strategies. Proc Natl Acad Sci USA 2003, 100: 12978-12983. 10.1073/pnas.2133782100PubMedCentralCrossRefPubMed Perez M, Craven RC, de la Torre JC: The small RING finger protein Z drives arenavirus budding: implications for antiviral strategies. Proc Natl Acad Sci USA 2003, 100: 12978-12983. 10.1073/pnas.2133782100PubMedCentralCrossRefPubMed
34.
go back to reference Harty RN, Brown ME, Wang G, Huibregtse J, Hayes FP: A PPxY motif within the VP40 protein of Ebola virus interacts physically and functionally with a ubiquitin ligase: implications for filovirus budding. Proc Natl Acad Sci USA 2000, 97: 13871-13876. 10.1073/pnas.250277297PubMedCentralCrossRefPubMed Harty RN, Brown ME, Wang G, Huibregtse J, Hayes FP: A PPxY motif within the VP40 protein of Ebola virus interacts physically and functionally with a ubiquitin ligase: implications for filovirus budding. Proc Natl Acad Sci USA 2000, 97: 13871-13876. 10.1073/pnas.250277297PubMedCentralCrossRefPubMed
35.
go back to reference Licata JM, Simpson-Holley M, Wright NT, Han Z, Paragas J, Harty RN: Overlapping motifs (PTAP and PPEY) within the Ebola virus VP40 protein function independently as late budding domains: involvement of host proteins TSG101 and VPS-4. J Virol 2003, 77: 1812-1819. 10.1128/JVI.77.3.1812-1819.2003PubMedCentralCrossRefPubMed Licata JM, Simpson-Holley M, Wright NT, Han Z, Paragas J, Harty RN: Overlapping motifs (PTAP and PPEY) within the Ebola virus VP40 protein function independently as late budding domains: involvement of host proteins TSG101 and VPS-4. J Virol 2003, 77: 1812-1819. 10.1128/JVI.77.3.1812-1819.2003PubMedCentralCrossRefPubMed
36.
go back to reference Harty RN, Brown ME, McGettigan JP, Wang G, Jayakar HR, Huibregtse JM, Whitt MA, Schnell MJ: Rhabdoviruses and the cellular ubiquitin-proteasome system: a budding interaction. J Virol 2001, 75: 10623-10629. 10.1128/JVI.75.22.10623-10629.2001PubMedCentralCrossRefPubMed Harty RN, Brown ME, McGettigan JP, Wang G, Jayakar HR, Huibregtse JM, Whitt MA, Schnell MJ: Rhabdoviruses and the cellular ubiquitin-proteasome system: a budding interaction. J Virol 2001, 75: 10623-10629. 10.1128/JVI.75.22.10623-10629.2001PubMedCentralCrossRefPubMed
37.
go back to reference Harty RN, Paragas J, Sudol M, Palese P: A proline-rich motif within the matrix protein of vesicular stomatitis virus and rabies virus interacts with WW domains of cellular proteins: implications for viral budding. J Virol 1999, 73: 2921-2929.PubMedCentralPubMed Harty RN, Paragas J, Sudol M, Palese P: A proline-rich motif within the matrix protein of vesicular stomatitis virus and rabies virus interacts with WW domains of cellular proteins: implications for viral budding. J Virol 1999, 73: 2921-2929.PubMedCentralPubMed
38.
go back to reference Schmitt AP, Leser GP, Morita E, Sundquist WI, Lamb RA: Evidence for a new viral late-domain core sequence, FPIV, necessary for budding of a paramyxovirus. J Virol 2005, 79: 2988-2997. 10.1128/JVI.79.5.2988-2997.2005PubMedCentralCrossRefPubMed Schmitt AP, Leser GP, Morita E, Sundquist WI, Lamb RA: Evidence for a new viral late-domain core sequence, FPIV, necessary for budding of a paramyxovirus. J Virol 2005, 79: 2988-2997. 10.1128/JVI.79.5.2988-2997.2005PubMedCentralCrossRefPubMed
39.
go back to reference Irie T, Shimazu Y, Yoshida T, Sakaguchi T: The YLDL Sequence within Sendai Virus M Protein Is Critical for Budding of Virus-Like Particles and Interacts with Alix/AIP1 Independently of C Protein. J Virol 2007, 81: 2263-2273. 10.1128/JVI.02218-06PubMedCentralCrossRefPubMed Irie T, Shimazu Y, Yoshida T, Sakaguchi T: The YLDL Sequence within Sendai Virus M Protein Is Critical for Budding of Virus-Like Particles and Interacts with Alix/AIP1 Independently of C Protein. J Virol 2007, 81: 2263-2273. 10.1128/JVI.02218-06PubMedCentralCrossRefPubMed
40.
go back to reference Irie T, Harty RN: L-domain flanking sequences are important for host interactions and efficient budding of vesicular stomatitis virus recombinants. J Virol 2005, 79: 12617-12622. 10.1128/JVI.79.20.12617-12622.2005PubMedCentralCrossRefPubMed Irie T, Harty RN: L-domain flanking sequences are important for host interactions and efficient budding of vesicular stomatitis virus recombinants. J Virol 2005, 79: 12617-12622. 10.1128/JVI.79.20.12617-12622.2005PubMedCentralCrossRefPubMed
41.
go back to reference Martin-Serrano J, Perez-Caballero D, Bieniasz PD: Context-Dependent Effects of L Domains and Ubiquitination on Viral Budding. J Virol 2004, 78: 5554-5563. 10.1128/JVI.78.11.5554-5563.2004PubMedCentralCrossRefPubMed Martin-Serrano J, Perez-Caballero D, Bieniasz PD: Context-Dependent Effects of L Domains and Ubiquitination on Viral Budding. J Virol 2004, 78: 5554-5563. 10.1128/JVI.78.11.5554-5563.2004PubMedCentralCrossRefPubMed
42.
go back to reference Strack B, Calistri A, Craig S, Popova E, Gottlinger HG: AIP1/ALIX is a binding partner for HIV-1 p6 and EIAV p9 functioning in virus budding. Cell 2003, 114: 689-699. 10.1016/S0092-8674(03)00653-6CrossRefPubMed Strack B, Calistri A, Craig S, Popova E, Gottlinger HG: AIP1/ALIX is a binding partner for HIV-1 p6 and EIAV p9 functioning in virus budding. Cell 2003, 114: 689-699. 10.1016/S0092-8674(03)00653-6CrossRefPubMed
43.
go back to reference Accola MA, Strack B, Gottlinger HG: Efficient particle production by minimal Gag constructs which retain the carboxy-terminal domain of human immunodeficiency virus type 1 capsid-p2 and a late assembly domain. J Virol 2000, 74: 5395-5402. 10.1128/JVI.74.12.5395-5402.2000PubMedCentralCrossRefPubMed Accola MA, Strack B, Gottlinger HG: Efficient particle production by minimal Gag constructs which retain the carboxy-terminal domain of human immunodeficiency virus type 1 capsid-p2 and a late assembly domain. J Virol 2000, 74: 5395-5402. 10.1128/JVI.74.12.5395-5402.2000PubMedCentralCrossRefPubMed
44.
go back to reference Irie T, Licata JM, McGettigan JP, Schnell MJ, Harty RN: Budding of PPxY-containing rhabdoviruses is not dependent on host proteins TGS101 and VPS4A. J Virol 2004, 78: 2657-2665. 10.1128/JVI.78.6.2657-2665.2004PubMedCentralCrossRefPubMed Irie T, Licata JM, McGettigan JP, Schnell MJ, Harty RN: Budding of PPxY-containing rhabdoviruses is not dependent on host proteins TGS101 and VPS4A. J Virol 2004, 78: 2657-2665. 10.1128/JVI.78.6.2657-2665.2004PubMedCentralCrossRefPubMed
45.
go back to reference Puffer BA, Parent LJ, Wills JW, Montelaro RC: Equine infectious anemia virus utilizes a YXXL motif within the late assembly domain of the Gag p9 protein. J Virol 1997, 71: 6541-6546.PubMedCentralPubMed Puffer BA, Parent LJ, Wills JW, Montelaro RC: Equine infectious anemia virus utilizes a YXXL motif within the late assembly domain of the Gag p9 protein. J Virol 1997, 71: 6541-6546.PubMedCentralPubMed
46.
go back to reference Sakaguchi T, Kato A, Sugahara F, Shimazu Y, Inoue M, Kiyotani K, Nagai Y, Yoshida T: AIP1/Alix is a binding partner of Sendai virus C protein and facilitates virus budding. J Virol 2005, 79: 8933-8941. 10.1128/JVI.79.14.8933-8941.2005PubMedCentralCrossRefPubMed Sakaguchi T, Kato A, Sugahara F, Shimazu Y, Inoue M, Kiyotani K, Nagai Y, Yoshida T: AIP1/Alix is a binding partner of Sendai virus C protein and facilitates virus budding. J Virol 2005, 79: 8933-8941. 10.1128/JVI.79.14.8933-8941.2005PubMedCentralCrossRefPubMed
47.
go back to reference Gosselin-Grenet AS, Marq JB, Abrami L, Garcin D, Roux L: Sendai virus budding in the course of an infection does not require Alix and VPS4A host factors. Virology 2007, 365: 101-112. 10.1016/j.virol.2007.03.039CrossRefPubMed Gosselin-Grenet AS, Marq JB, Abrami L, Garcin D, Roux L: Sendai virus budding in the course of an infection does not require Alix and VPS4A host factors. Virology 2007, 365: 101-112. 10.1016/j.virol.2007.03.039CrossRefPubMed
48.
go back to reference Johnson RF, McCarthy SE, Godlewski PJ, Harty RN: Ebola virus VP35–VP40 interaction is sufficient for packaging 3E-5E minigenome RNA into virus-like particles. J Virol 2006, 80: 5135-5144. 10.1128/JVI.01857-05PubMedCentralCrossRefPubMed Johnson RF, McCarthy SE, Godlewski PJ, Harty RN: Ebola virus VP35–VP40 interaction is sufficient for packaging 3E-5E minigenome RNA into virus-like particles. J Virol 2006, 80: 5135-5144. 10.1128/JVI.01857-05PubMedCentralCrossRefPubMed
49.
go back to reference Licata JM, Johnson RF, Han Z, Harty RN: Contribution of ebola virus glycoprotein, nucleoprotein, and VP24 to budding of VP40 virus-like particles. J Virol 2004, 78: 7344-7351. 10.1128/JVI.78.14.7344-7351.2004PubMedCentralCrossRefPubMed Licata JM, Johnson RF, Han Z, Harty RN: Contribution of ebola virus glycoprotein, nucleoprotein, and VP24 to budding of VP40 virus-like particles. J Virol 2004, 78: 7344-7351. 10.1128/JVI.78.14.7344-7351.2004PubMedCentralCrossRefPubMed
50.
go back to reference Chen BJ, Lamb RA: Mechanisms for enveloped virus budding: can some viruses do without an ESCRT? Virology 2008, 372: 221-232. 10.1016/j.virol.2007.11.008PubMedCentralCrossRefPubMed Chen BJ, Lamb RA: Mechanisms for enveloped virus budding: can some viruses do without an ESCRT? Virology 2008, 372: 221-232. 10.1016/j.virol.2007.11.008PubMedCentralCrossRefPubMed
51.
go back to reference Munshi UM, Kim J, Nagashima K, Hurley JH, Freed EO: An Alix fragment potently inhibits HIV-1 budding: Characterization of binding to retroviral YPXL late domains. J Biol Chem 2006, 282: 3847-3855. 10.1074/jbc.M607489200CrossRefPubMed Munshi UM, Kim J, Nagashima K, Hurley JH, Freed EO: An Alix fragment potently inhibits HIV-1 budding: Characterization of binding to retroviral YPXL late domains. J Biol Chem 2006, 282: 3847-3855. 10.1074/jbc.M607489200CrossRefPubMed
52.
go back to reference Gottlinger HG, Dorfman T, Sodroski JG, Haseltine WA: Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release. Proc Natl Acad Sci USA 1991, 88: 3195-3199. 10.1073/pnas.88.8.3195PubMedCentralCrossRefPubMed Gottlinger HG, Dorfman T, Sodroski JG, Haseltine WA: Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release. Proc Natl Acad Sci USA 1991, 88: 3195-3199. 10.1073/pnas.88.8.3195PubMedCentralCrossRefPubMed
53.
go back to reference Neumann G, Ebihara H, Takada A, Noda T, Kobasa D, Jasenosky LD, Watanabe S, Kim JH, Feldmann H, Kawaoka Y: Ebola virus VP40 late domains are not essential for viral replication in cell culture. J Virol 2005, 79: 10300-10307. 10.1128/JVI.79.16.10300-10307.2005PubMedCentralCrossRefPubMed Neumann G, Ebihara H, Takada A, Noda T, Kobasa D, Jasenosky LD, Watanabe S, Kim JH, Feldmann H, Kawaoka Y: Ebola virus VP40 late domains are not essential for viral replication in cell culture. J Virol 2005, 79: 10300-10307. 10.1128/JVI.79.16.10300-10307.2005PubMedCentralCrossRefPubMed
54.
go back to reference Khor R, McElroy LJ, Whittaker GR: The ubiquitin-vacuolar protein sorting system is selectively required during entry of influenza virus into host cells. Traffic 2003, 4: 857-868. 10.1046/j.1398-9219.2003.0140.xCrossRefPubMed Khor R, McElroy LJ, Whittaker GR: The ubiquitin-vacuolar protein sorting system is selectively required during entry of influenza virus into host cells. Traffic 2003, 4: 857-868. 10.1046/j.1398-9219.2003.0140.xCrossRefPubMed
55.
go back to reference Ott DE, Coren LV, Sowder RC 2nd, Adams J, Nagashima K, Schubert U: Equine infectious anemia virus and the ubiquitin-proteasome system. J Virol 2002, 76: 3038-3044. 10.1128/JVI.76.6.3038-3044.2002PubMedCentralCrossRefPubMed Ott DE, Coren LV, Sowder RC 2nd, Adams J, Nagashima K, Schubert U: Equine infectious anemia virus and the ubiquitin-proteasome system. J Virol 2002, 76: 3038-3044. 10.1128/JVI.76.6.3038-3044.2002PubMedCentralCrossRefPubMed
56.
go back to reference Patnaik A, Chau V, Li F, Montelaro RC, Wills JW: Budding of equine infectious anemia virus is insensitive to proteasome inhibitors. J Virol 2002, 76: 2641-2647. 10.1128/JVI.76.6.2641-2647.2002PubMedCentralCrossRefPubMed Patnaik A, Chau V, Li F, Montelaro RC, Wills JW: Budding of equine infectious anemia virus is insensitive to proteasome inhibitors. J Virol 2002, 76: 2641-2647. 10.1128/JVI.76.6.2641-2647.2002PubMedCentralCrossRefPubMed
57.
go back to reference Berhane Y, Berry JD, Ranadheera C, Marszal P, Nicolas B, Yuan X, Czub M, Weingartl H: Production and characterization of monoclonal antibodies against binary ethylenimine inactivated Nipah virus. J Virol Methods 2006, 132: 59-68. 10.1016/j.jviromet.2005.09.005CrossRefPubMed Berhane Y, Berry JD, Ranadheera C, Marszal P, Nicolas B, Yuan X, Czub M, Weingartl H: Production and characterization of monoclonal antibodies against binary ethylenimine inactivated Nipah virus. J Virol Methods 2006, 132: 59-68. 10.1016/j.jviromet.2005.09.005CrossRefPubMed
58.
go back to reference Clamp M, Cuff J, Searle SM, Barton GJ: The Jalview Java Alignment Editor. Bioinformatics 2004, 20: 426-427. 10.1093/bioinformatics/btg430CrossRefPubMed Clamp M, Cuff J, Searle SM, Barton GJ: The Jalview Java Alignment Editor. Bioinformatics 2004, 20: 426-427. 10.1093/bioinformatics/btg430CrossRefPubMed
Metadata
Title
The YPLGVG sequence of the Nipah virus matrix protein is required for budding
Authors
Jared R Patch
Ziying Han
Sarah E McCarthy
Lianying Yan
Lin-Fa Wang
Ronald N Harty
Christopher C Broder
Publication date
01-12-2008
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2008
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/1743-422X-5-137

Other articles of this Issue 1/2008

Virology Journal 1/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.